Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration

Jiang, Y., Alam, J. J., Gomperts, S. N., Maruff, P., Lemstra, A. W., Germann, U. A., Stavrides, P. H., Darji, S., Malampati, S., Peddy, J., Bleiwas, C., Pawlik, M., Pensalfini, A., Yang, D.-S., Subbanna, S., Basavarajappa, B. S., Smiley, J. F., Gardner, A., Blackburn, K., … Nixon, R. A. (2022). Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-32944-3
Authors:
Ying Jiang
John J. Alam
Stephen N. Gomperts
Paul Maruff
Afina W. Lemstra
Ursula A. Germann
Philip H. Stavrides
Sandipkumar Darji
Sandeep Malampati
James Peddy
Cynthia Bleiwas
Monika Pawlik
Anna Pensalfini
Dun-Sheng Yang
Shivakumar Subbanna
Balapal S. Basavarajappa
John F. Smiley
Amanda Gardner
Kelly Blackburn
Hui-May Chu
Niels D. Prins
Charlotte E. Teunissen
John E. Harrison
Philip Scheltens
Ralph A. Nixon
Affiliated Authors:
Balapal S. Basavarajappa
Publication Type:
Article
Unique ID:
10.1038/s41467-022-32944-3
PMID:
Publication Date:
Data Source:
Scopus

Record Created: